Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Assessment of CHA2DS2-VASc score for predicting cardiovascular and cerebrovascular outcomes in acute myocardial infarction patients.

Li CY, Chang CJ, Chung WJ, Lin CJ, Hsueh SK, Lee CH, Wu CJ, Tsai TH, Cheng CI.

Medicine (Baltimore). 2018 Jul;97(28):e11230. doi: 10.1097/MD.0000000000011230.

2.

Another Nail in the Coffin for Fish Oil Supplements.

Abbasi J.

JAMA. 2018 May 8;319(18):1851-1852. doi: 10.1001/jama.2018.2498. No abstract available.

PMID:
29710294
3.

Impact of bone marrow mononuclear cells therapy on left ventricular function in patients with ST-elevated myocardial infarction: A meta-analysis.

Wang C, Han X, Li Y, Zhang B.

Medicine (Baltimore). 2018 Apr;97(16):e0359. doi: 10.1097/MD.0000000000010359.

4.

The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis.

Gu ZC, Zhang YJ, Pan MM, Zhang C, Liu XY, Wei AH, Su YJ.

Medicine (Baltimore). 2018 Mar;97(11):e0122. doi: 10.1097/MD.0000000000010122. Review.

5.

Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery.

Duncan D, Sankar A, Beattie WS, Wijeysundera DN.

Cochrane Database Syst Rev. 2018 Mar 6;3:CD004126. doi: 10.1002/14651858.CD004126.pub3. Review.

PMID:
29509957
6.

Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.

Mazzanti A, Maragna R, Vacanti G, Kostopoulou A, Marino M, Monteforte N, Bloise R, Underwood K, Tibollo V, Pagan E, Napolitano C, Bellazzi R, Bagnardi V, Priori SG.

J Am Coll Cardiol. 2017 Dec 19;70(24):3010-3015. doi: 10.1016/j.jacc.2017.10.025.

PMID:
29241489
7.

Rheumatic heart disease: infectious disease origin, chronic care approach.

Katzenellenbogen JM, Ralph AP, Wyber R, Carapetis JR.

BMC Health Serv Res. 2017 Nov 29;17(1):793. doi: 10.1186/s12913-017-2747-5. Review.

8.

Ventricular Arrhythmias.

Dresen WF, Ferguson JD.

Cardiol Clin. 2018 Feb;36(1):129-139. doi: 10.1016/j.ccl.2017.08.007. Epub 2017 Oct 27. Review.

PMID:
29173673
9.

The Subcutaneous Defibrillator.

Weinstock J, Madias C.

Card Electrophysiol Clin. 2017 Dec;9(4):775-783. doi: 10.1016/j.ccep.2017.08.007. Review.

PMID:
29173417
10.

Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned?

Sroubek J, Buxton AE.

Card Electrophysiol Clin. 2017 Dec;9(4):761-773. doi: 10.1016/j.ccep.2017.08.006. Epub 2017 Sep 28. Review.

PMID:
29173416
11.

Prediction and Prevention of Sudden Cardiac Death.

Morin DP, Homoud MK, Estes NAM 3rd.

Card Electrophysiol Clin. 2017 Dec;9(4):631-638. doi: 10.1016/j.ccep.2017.07.012. Review.

PMID:
29173406
12.

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP.

J Am Heart Assoc. 2017 Nov 18;6(11). pii: e006901. doi: 10.1161/JAHA.117.006901.

13.

The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication after Drug-Eluting StenT Implantation) Trial.

Suh JW, Lee SP, Park K, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS.

Int Heart J. 2017 Dec 12;58(6):853-860. doi: 10.1536/ihj.16-332. Epub 2017 Nov 8.

14.

Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.

Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T.

J Am Heart Assoc. 2017 Nov 8;6(11). pii: e006513. doi: 10.1161/JAHA.117.006513.

15.

Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

Bossard M, Granger CB, Tanguay JF, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR.

J Am Heart Assoc. 2017 Nov 3;6(11). pii: e006577. doi: 10.1161/JAHA.117.006577.

16.

Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.

Hohenstein B, Julius U, Lansberg P, Jaeger B, Mellwig KP, Weiss N, Graehlert X, Roeder I, Ramlow W.

Atheroscler Suppl. 2017 Nov;30:180-186. doi: 10.1016/j.atherosclerosissup.2017.05.009. Epub 2017 Jun 1.

PMID:
29096835
17.

Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients.

Awada G, de Azambuja E, Awada A.

Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1205-1215. doi: 10.1080/17425255.2017.1398733. Epub 2017 Nov 6. Review.

PMID:
29088977
18.

The effect of desflurane and propofol protocols on preconditioning.

Onk D, Ozcelik F, Kuyrukluyıldız U, Gunay M, Onk A, Ayazoglu TA, Coban A, Alagol A.

Adv Clin Exp Med. 2017 Aug;26(5):817-823. doi: 10.17219/acem/61045.

19.

Effect of quercetin on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease.

Chekalina NI, Shut SV, Trybrat TA, Burmak YH, Petrov YY, Manusha YI, Kazakov YM.

Wiad Lek. 2017;70(4):707-711.

PMID:
29064791
20.

Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients-A systematic review and meta-analysis.

Bergau L, Tichelbäcker T, Kessel B, Lüthje L, Fischer TH, Friede T, Zabel M.

PLoS One. 2017 Oct 17;12(10):e0186387. doi: 10.1371/journal.pone.0186387. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center